Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
[4] In the SURMOUNT-1 obesity trial, a 72-week placebo-controlled study in 2,539 adults with obesity (without diabetes), mean weight change was 15.0%, 19.5%, and 20.9% at the 5, 10, and 15 mg doses versus 3.1% for placebo
SGLT2 inhibitors vs GLP-1 receptor agonists and clinical outcomes in patients with diabetes with/without atrial fibrillation
Approval of tirzepatide for apnea was given on the basis of a study that showed the drug reduced the condition by up to 62.8 percent
It may enhance brain function by increasing neurotransmitter levels and protecting against oxidative stress
US$ 24.88
US$ 23.62
US$ 22.28
US$ 22.72
US$ 29.65
US$ 21.34
US$ 27.43
